Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Daniel_Tassé
|
| gptkbp:clinicalTrialPhase |
gptkb:PEPITES
gptkb:REALISE |
| gptkbp:country |
gptkb:France
|
| gptkbp:focusesOn |
immunotherapy
allergy treatments |
| gptkbp:foundedYear |
2002
|
| gptkbp:founder |
gptkb:Denis_Chêne
gptkb:Olivier_Dupont gptkb:Pierre-Henri_Benhamou |
| gptkbp:headquartersLocation |
gptkb:Montrouge,_France
|
| https://www.w3.org/2000/01/rdf-schema#label |
DBV Technologies
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Viaskin_Peanut
|
| gptkbp:specializesIn |
epicutaneous immunotherapy
|
| gptkbp:stockExchange |
gptkb:NASDAQ
gptkb:Euronext_Paris |
| gptkbp:stockSymbol |
gptkb:DBV
gptkb:DBVT |
| gptkbp:website |
https://www.dbv-technologies.com/
|
| gptkbp:bfsParent |
gptkb:DBV
|
| gptkbp:bfsLayer |
6
|